MFDS — authorised 1 April 1968
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
🇰🇷 Desferal in South Korea
MFDS authorised Desferal on 1 April 1968
Marketing authorisation
Desferal in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Desferal approved in South Korea?
Yes. MFDS authorised it on 1 April 1968.
Who is the marketing authorisation holder for Desferal in South Korea?
NOVARTIS holds the South Korean marketing authorisation.